A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment

American Journal of Psychiatry

Volumn 159, Issue 1, 2002, Pages 96-102

  Romano, Steven J ^b   Halmi, Katherine A ^b   Sarkar, Neena P ^b   Koke, Stephanie C ^a   Lee, Julia S ^b  

^a ELI LILLY AND COMPANY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ARTICLE; BINGE EATING DISORDER; BULIMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VOMITING; ADOLESCENT; ADULT; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; LONG TERM CARE; MALE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; BULIMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0036356381     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.1.96     Document Type: Article

References (32)

1. Herzog DB, Nussbaum KM, Marmor AK: Comorbidity and outcome in eating disorders. Psychiatr Clin North Am 1996; 19:843-859
2. Kendler KS, MacLean C, Neale M, Kessler R, Heath A, Eaves L: The genetic epidemiology of bulimia nervosa. Am J Psychiatry 1991; 148:1627-1637
3. Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC: Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Arch Gen Psychiatry 1992; 49:852-861
4. McBride PA, Anderson GM, Khait VD, Sunday SR, Halmi KA: Serotonergic responsivity in eating disorders. Psychopharmacol Bull 1991; 27:365-372
5. Leibowitz SF: The role of serotonin in eating disorders. Drugs 1990; 39(suppl3):33-48
6. Jimerson DC, Herzog DB: Pharmacologic approaches in the treatment of eating disorders. Harv Rev Psychiatry 1993; 1:82-93
7. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D: Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 1983; 140:554-558
8. Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM: Treating bulimia with desipramine: a placebo-controlled double-blind study. Arch Gen Psychiatry 1986; 43:182-186
9. Agras WS, Dorian BG, Kirkley BG, Arnow B, Bachman J: Imipramine in the treatment of bulimia: a double-blind controlled study. Int J Eat Disord 1987; 6:29-38
10. Kaplan AS, Garfinkel PE, Garner DM: Bulimia treated with carbamazepine and imipramine, in 1987 Annual Meeting New Research Program. Washington, DC, American Psychiatric Association, 1987, p 127
11. Price WA, Babai MR: Antidepressant drug therapy for bulimia: current status revisited (letter). J Clin Psychiatry 1987; 48:385
12. Barlow J, Blouin J, Blouin A, Perez E: Treatment of bulimia with desipramine: a double-blind crossover study. Can J Psychiatry 1988; 33:129-133
13. Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, Cato A: Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988; 49:262-266
14. Walsh BT, Gladis M, Rose SP, Stewart JW, Stetner F, Glassman AH: Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry 1988; 45:471-475
15. Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, Garfinkel PE: A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol 1988; 8:391-396
16. Pope HG Jr, Keck PE Jr, McElroy SM, Hudson JI: A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989; 9:254-259
17. Fichter MM, Leibl K, Rief W, Brunner E, Schmidt-Auberger S, Engel RR: Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991; 24:1-7
18. Fluoxetine Bulimia Nervosa Collaborative Study Group: Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992; 49:139-147
19. Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH (Fluoxetine Bulimia Nervosa Research Group): Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995; 166:660-666
20. Keel PK, Mitchell JE: Outcome in bulimia nervosa. Am J Psychiatry 1997; 154:313-321
21. Garner DM, Olmsted MP, Polivy J: Eating Disorder Inventory. Odessa, Fla, Psychological Assessment Resources, 1983
22. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM: The Yale-Brown-Cornell Eating Disorder Scale: development, use, reliability, and validity. J Psychiatr Res 1994; 28:425-445
23. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976, pp 218-222
24. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
25. Greenwood M: The Natural Duration of Cancer: Reports on Public Health and Medical Subjects 33. London, Her Majesty's Stationery Office, 1926, pp 1-26
26. Gray RJ, Tsiatis AA: A linear rank test for use when the main interest is in difference in cure rates. Biometrics 1989; 45:899-904
27. Akritas MG, Arnold SF, Brunner E: Nonparametric hypotheses and rank statistics for unbalanced factorial designs. J Am Statistical Assoc 1997; 92:258-265
28. Mitchell JE, Raymond N, Specker S: A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa. Int J Eat Disord 1993; 14:229-247
29. Goldbloom DS, Olmsted M, Davis R, Clewes J, Heinmaa M, Rockert W, Shaw B: A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome. Behav Res Ther 1997; 35:803-811
30. Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R: Comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990; 47:149-157
31. Agras WS, Rossiter EM, Arnow B, Schneider JA, Teich CF, Raeburn SD, Bruce B, Perl M, Koran LM: Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry 1992; 149:82-87
32. Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, Fleiss J, Waternaux C: Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry 1997; 154:523-531